CAMURUS Trademark

Trademark Overview


On Thursday, June 30, 2022, a trademark application was filed for CAMURUS with the United States Patent and Trademark Office. The USPTO has given the CAMURUS trademark a serial number of 97483616. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Wednesday, October 25, 2023. This trademark is owned by Camurus AB. The CAMURUS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal, cognitive, and substance abuse related diseases and disorders; subcutaneous drug delivery agents sold as a component of pharmaceutical preparations for the treatment of genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal, cognitive, and substance abuse related diseases and disorders; drug delivery agents in the form of subcutaneous compounds that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; sustained or extended release drug delivery agents sold as a component of pharmaceutical preparations for the treatment of genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal, cognitive, and substance abuse related diseases and disorders; drug delivery agents in the f...
camurus

General Information


Serial Number97483616
Word MarkCAMURUS
Filing DateThursday, June 30, 2022
Status730 - FIRST EXTENSION - GRANTED
Status DateWednesday, October 25, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 21, 2023

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal, cognitive, and substance abuse related diseases and disorders; subcutaneous drug delivery agents sold as a component of pharmaceutical preparations for the treatment of genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal, cognitive, and substance abuse related diseases and disorders; drug delivery agents in the form of subcutaneous compounds that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; sustained or extended release drug delivery agents sold as a component of pharmaceutical preparations for the treatment of genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal, cognitive, and substance abuse related diseases and disorders; drug delivery agents in the form of sustained or extended release drug delivery compounds that provide sustained or extended release of the active ingredients for a wide variety of pharmaceuticals; lipid-based drug delivery agents sold as a component of pharmaceutical preparations for the treatment of genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal, cognitive, and substance abuse related diseases and disorders administered via subcutaneous injection; veterinary vaccines; sanitary preparations for medical use; dietetic foods adapted for medical use; food for babies; dietary supplements for human beings and animals; medical plasters; gauze and bandages for dressings; teeth filling material; dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, July 20, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCamurus AB
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressLund 22370
SE

Party NameCamurus AB
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressLund 22370
SE

Trademark Events


Event DateEvent Description
Friday, October 27, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 25, 2023SOU EXTENSION 1 GRANTED
Wednesday, October 25, 2023SOU EXTENSION 1 FILED
Wednesday, October 25, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, May 16, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 21, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 21, 2023PUBLISHED FOR OPPOSITION
Wednesday, March 1, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, February 15, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 15, 2023ASSIGNED TO EXAMINER
Wednesday, July 20, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, July 4, 2022NEW APPLICATION ENTERED